Infant Bacterial Therapeutics AB
IBT-B.ST
#9383
Rank
NZ$0.11 B
Marketcap
$8.32
Share price
5.91%
Change (1 day)
-38.24%
Change (1 year)

EPS for Infant Bacterial Therapeutics AB (IBT-B.ST)

EPS in 2024 (TTM): -$1.55

According to Infant Bacterial Therapeutics AB's latest financial reports the company's current EPS (TTM) is -$1.65. In 2023 the company made an earnings per share (EPS) of -$1.72 a decrease over its 2022 EPS that were of -$0.98.

EPS history for Infant Bacterial Therapeutics AB from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$1.55-10.29%
2023-$1.7276.22%
2022-$0.9826.49%
2021-$0.77-43.37%
2020-$1.3777.11%
2019-$0.775.56%
2018-$0.73-43.39%
2017-$1.29-10.87%
2016-$1.45-30.65%
2015-$2.09359.45%
2014-$0.45